Table 4 Views of the hypertensive patients on statements about social value, risk and benefit of the pragmatic randomized controlled trial (pRCT) scenarios

It is valuable to study whether one treatment option is more effective than the other for treating high blood pressure

Drug pRCT ^a

Dose-timing pRCT ^b

3.5

1.8

5.9

4.8

90.6

93.5

Patients who participate in the randomized trial face greater risks than patients who receive usual care

Drug pRCT ^a

Dose-timing pRCT ^b

31.8

40.5

27.6

25.6

40.6

33.9

Patients who participate in the randomized trial are more likely to improve (lower) their high blood pressure than patients who receive usual care.

Drug pRCT ^a

Dose-timing pRCT ^b

17.6

14.9

36.5

35.7

45.9

49.4